Company intelligence / Profile preview

D&V Farma

Ownership: Private
Development stage: Other

Overview

D&V Farma develops and licenses innovative medical devices—primarily for ophthalmology—with several products certified as Class IIa/IIb medical devices in Europe. Clinical and preclinical evidence supports their portfolio, which includes patented or patent-pending formulations for ocular indications such as dry eye in diabetics and tools for vitreoretinal surgery.

Therapeutic areas: Ophthalmology
Modalities: Medical deviceSmall molecule (as part of dietary supplements)
Industry: Consumable Medical Devices

Partnerships

Collaborations with university professors/researchers and industry professionals are core to their business model; no major pharma partnerships named publicly

Beyond the preview

Go deeper on D&V Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D&V Farma.

Explore the full profile